Cytomx Therapeutics, Inc. · NASDAQ:CTMX
FMR LLC reported a 12.40% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Oct 31, 2025 · Filed Nov 7, 2025
FMR LLC reported a 12.40% stake in Cytomx Therapeutics, Inc., 20,519,967 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 12.40%
- Shares
- 20,519,967
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 12.40% | 20,519,967 |
| Abigail P. Johnson | 12.40% | 20,519,967 |
Source
Related
- Cytomx Therapeutics, Inc.
- FMR LLC
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Feb 5, 2026
- Schedule 13G/A · FMR LLC · Nov 5, 2025
- Schedule 13G · FMR LLC · Aug 6, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026